ArticlePsychiatry and clinical neurosciences2020
Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Abstract readEvaluation StudyLetter
In one paragraph
Article in Psychiatry and clinical neurosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Association Between Psychiatrists' Subjective Clinical Behavior Scores and Objective Quality Indicators Based on Discharge Prescriptions: A Nationwide Multicenter Study Based on the EGUIDE Project.Neuropsychopharmacology reports · 2026Observational
- Prescribing medications for attention-deficit/hyperactivity disorder in children: a retrospective analysis of a Japanese health insurance claims database.BMC psychiatry · 2026Article
- Clinical behavior toward outpatients with major depressive disorder based on guideline education for psychiatrists.PCN reports : psychiatry and clinical neurosciences · 2025Article
- Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter Study.Neuropsychopharmacology reports · 2025Observational
- Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting.BMC psychiatry · 2025Article
- Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study.BMC psychiatry · 2025Observational
- Long-term effectiveness and cost-effectiveness of guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: 24-month follow-up.Internet interventions · 2024Article
- Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia.Schizophrenia (Heidelberg, Germany) · 2023Article
- Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.Psychiatry and clinical neurosciences · 2023Article
- Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.The international journal of neuropsychopharmacology · 2023Article
- Article
- Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.Neuropsychopharmacology reports · 2023Article
- Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.Neuropsychopharmacology reports · 2023Article
- The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.Annals of general psychiatry · 2022Article
- Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".Neuropsychopharmacology reports · 2022Article
- Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.The international journal of neuropsychopharmacology · 2022Article
- Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.Neuropsychopharmacology reports · 2022Article
- Article
- Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study.Neuropsychopharmacology reports · 2022Article
- Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics.Frontiers in psychiatry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
57 authors.
Hitoshi IidaDepartment of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Junichi IgaDepartment of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.ORCID https://orcid.org/0000-0003-4409-3096
Naomi HasegawaDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Yuka YasudaMedical Corporation Foster, Osaka, Japan.ORCID https://orcid.org/0000-0002-2746-1590
Tomoya YamamotoDepartment of Pharmacy, Osaka University Hospital, Osaka, Japan.
Kenichiro MiuraDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Junya MatsumotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Atsunobu MurataDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Kazuyoshi OgasawaraCenter for Postgraduate Clinical Training and Career Development, Nagoya University Hospital, Aichi, Japan.
Hisashi YamadaDepartment of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan.
Hikaru HoriDepartment of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Kayo IchihashiDeaprtment of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan.
Naoki HashimotoDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.ORCID https://orcid.org/0000-0001-8311-7148
Kazutaka OhiDepartment of Psychiatry and Psychotherapy, Gifu University Graduate School of Medicine, Gifu, Japan.
Norio Yasui-FurukoriDepartment of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Takashi TsuboiDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Toshinori NakamuraDepartment of Psychiatry, Shinshu University School of Medicine, Nagano, Japan.
Masahide UsamiDepartment of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba, Japan.
Ryuji FurihataDepartment of Psychiatry, Nihon University School of Medicine, Tokyo, Japan.
Yoshikazu TakaesuDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9169-3249
Kunihiro IwamotoDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan.
Nobuhiro SugiyamaDepartment of Applied Occupational Therapy, Shinshu University School of Health Sciences, Nagano, Japan.
Taishiro KishimotoDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0557-8648
Naohisa TsujinoDepartment of Neuropsychiatry, School of Medicine, Faculty of Medicine, Toho University, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5507-8946
Hiroki YamadaDepartment of Psychiatry, Showa University Northern Yokohama Hospital, Kanagawa, Japan.
Akitoyo HishimotoDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Kiyotaka NemotoDepartment of Psychiatry, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.ORCID https://orcid.org/0000-0001-8623-9829
Kiyokazu AtakeDepartment of Psychiatry, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Hiroyuki MuraokaDepartment of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.
Eiichi KatsumotoKatsumoto Mental Clinic, Osaka, Japan.
Satoru OishiDepartment of Psychiatry, Kitasato University School of Medicine, Kanagawa, Japan.
Takahiko InagakiAdolescent Mental Health Service, Biwako Hospital, Shiga, Japan.
Fumiaki ItoDepartment of Psychiatry, Tohoku University Hospital, Miyagi, Japan.
Yayoi ImamuraDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Mikio KidoDepartment of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
Tatsuya NagasawaDepartment of Neuropsychiatry, Kanazawa Medical University, Ishikawa, Japan.
Shusuke NumataDepartment of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.
Shinichiro OchiDepartment of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan.ORCID https://orcid.org/0000-0003-2263-3477
Masaaki IwataDepartment of Neuropsychiatry, Faculty of Medicine, Tottori University, Tottori, Japan.
Hidenaga YamamoriDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
Junichi FujitaDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Toshiaki OnitsukaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Satoshi YamamuraSuzuka Kosei Hospital, Mie, Japan.
Manabu MakinodanDepartment of Psychiatry, Nara Medical University School of Medicine, Nara, Japan.ORCID https://orcid.org/0000-0003-4339-9413
Michiko FujimotoDepartment of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Yoichiro TakayanagiDepartment of Neuropsychiatry, University of Toyama School of Medicine, Toyama, Japan.
Kenji TakezawaMedical Corporation Matsuzaki Hospital, Toyohashi Mental Care Center, Aichi, Japan.
Hiroshi KomatsuDepartment of Psychiatry, Tohoku University Hospital, Miyagi, Japan.
Kentaro FukumotoDepartment of Neuropsychiatry, Iwate Medical University, Iwate, Japan.
Shinichiro TamaiDepartment of Neuropsychiatry, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Hirotaka YamagataDivision of Neuropsychiatry, Department of Neuroscience, Yamaguchi University School of Medicine, Yamaguchi, Japan.
Chika KubotaDepartment of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Tadasu HoraiDepartment of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
Ken InadaDepartment of Psychiatry, Tokyo Women's Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3073-4588
Koichiro WatanabeDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
Hiroaki KawasakiDepartment of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Ryota HashimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5941-4238
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Health Services Needs and DemandPractice Guidelines as TopicCognitive Behavioral TherapyCross-Sectional StudiesDrug PrescriptionsElectroconvulsive TherapyHealth Services ResearchHospitalsHumansJapanMajor Depressive DisorderPolypharmacyQuality Indicators, Health CareRetrospective Studies
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.